There are some 1.5 million tests for chlamydia gonorrhoea- in NSW alone - 2019 - using the multiplex would halve the requirement for number of tests, reduce burden on the health system (repeat visits to doctors, repeat tests) and nsw as a client alone would match the revenue from the covid testing
annuity style revenue
Ann: Presenting at Bell potter healthcare conference, page-7
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
73.0¢ |
Change
0.005(0.69%) |
Mkt cap ! $165.6M | |||
| Open | High | Low | Value | Volume |
| 72.0¢ | 73.0¢ | 70.5¢ | $48.81K | 68.00K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | 69.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 75.0¢ | 22017 | 2 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| GSS (ASX) Chart |